Cross talk between p38MAPK and ERK is mediated through MAPK-mediated protein phosphatase 2A catalytic subunit α and MAPK phosphatase-1 expression in human leukemia U937 cells

Cellular Signalling

Volumn 25, Issue 9, 2013, Pages 1845-1851

  Liu, Wen Hsin ^a   Chen, Ying Jung ^a   Cheng, Tian Lu ^b   Lin, Shinne Ren ^b   Chang, Long Sen ^a  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Caffeine; ERK; MKP 1; P38 MAPK; PP2A

Indexed keywords

CAFFEINE; CALCIUM ION; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN C FOS; PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT ALPHA; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

CAFFEINE; DUAL SPECIFICITY PHOSPHATASE 1; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN PHOSPHATASE 2; U937 CELLS;

EID: 84879268502     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2013.05.021     Document Type: Article

References (29)

1. Boutros T., Chevet E., Metrakos P. Pharmacological Reviews 2008, 60:261-310.
2. Geest C.R., Coffer P.J. Journal of Leukocyte Biology 2009, 86:237-250.
3. Hommes D.W., Peppelenbosch M.P., van Deventer S.J. Gut 2003, 52:144-151.
4. Lee J.T., McCubrey J.A. Leukemia 2002, 16:486-507.
5. Liu Q., Hofmann P.A. American Journal of Physiology. Heart and Circulatory Physiology 2004, 286:H2204-H2212.
6. Wagner E.F., Nebreda A.R. Nature Reviews. Cancer 2009, 9:537-549.
7. Krishna M., Narang H. Cellular and Molecular Life Sciences 2008, 65:3525-3544.
8. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Science 1995, 270:1326-1331.
9. Junttila M.R., Li S.P., Westermarck J. The FASEB Journal 2008, 22:954-965.
10. Cheng B., Song J., Zou Y., Wang Q., Lei Y., Zhu C., Hu C. International Journal of Cardiology 2008, 134:356-365.
11. Franklin C.C., Kraft A.S. Journal of Biological Chemistry 1997, 272:16917-16923.
12. Liu W.H., Chang L.S. Journal of Cellular Physiology 2010, 224:775-785.
13. Janssens V., Goris J. Biochemical Journal 2001, 353:417-439.
14. Khew-Goodall Y., Mayer R.E., Maurer F., Stone S.R., Hemmings B.A. Biochemistry 1991, 30:89-97.
15. Gotz J., Probst A., Ehler E., Hemmings B., Kues W. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:12370-12375.
16. Liu W.H., Chang L.S. The International Journal of Biochemistry & Cell Biology 2011, 43:1708-1719.
17. Ribeiro J.A., Sebastiao A.M. Journal of Alzheimer's Disease 2010, 20(Suppl. 1):S3-S15.
18. Liu W.H., Chang L.S. Journal of Biological Chemistry 2010, 285:30506-30515.
19. Fujii K., Goldman E.H., Park H.R., Zhang L., Chen J., Fu H. Oncogene 2004, 23:5099-5104.
20. Christen V. Hepatology 2007, 46:558-565.
21. Furst R., Zahler S., Vollmar A.M. Endocrinology 2008, 149:3635-3642.
22. Sunahori K., Juang Y.T., Tsokos G.C. Journal of Immunology 2009, 182:1500-1508.
23. Casals-Casas C., Alvarez E., Serra M., de la Torre C., Farrera C., Sanchez-Tillo E., Caelles C., Lloberas J., Celada A. European Journal of Immunology 2009, 39:1902-1913.
24. Liu W.H., Chou W.M., Chang L.S. Carcinogenesis 2013, 34:818-827.
25. Liu W.H., Chen Y.L., Chang L.S. The International Journal of Biochemistry & Cell Biology 2012, 44:2212-2222.
26. Connolly S., Kingsbury T.J. Biochemical and Biophysical Research Communications 2010, 297:152-156.
27. Horrigan L.A., Kelly J.P., Connor T.J. Pharmacology and Therapeutics 2006, 111:877-892.
28. Wang X., Liu Y. Cellular Signalling 2007, 19:1372-1382.
29. Li L., Chen S.F., Liu Y. International Journal of Clinical and Experimental Medicine 2009, 2:48-67.